Rory Collins, co-director of Oxford University's clinical-trials service unit (which demonstrated the efficacy of aspirin against heart disease) has managed to piggy-back on a commercial trial in order to test the notion that folic acid, a food-supplement commonly given to pregnant women, may also prevent heart attacks.